| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |